MoCRA: Draft Guidance on Registration and Listing of Cosmetic Facilities and Products On 7 August 2023, the U.S. Food and Drug Administration, issued draft guidance on cosmetic product facility registrations and product listings, as mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). The draft guidance will assist stakeholders with cosmetic product facility registration and product listing submissions to FDA,...
CMR substances: New Regulation for Cosmetic Products What are CMR substances in cosmetics? CMR substances are carcinogenic, mutagenic or toxic to reproduction. In the EU they are classified under the CLP Regulation (EC) No 1272/2008 into: Category 1A (known human evidence), 1B (presumed from animal data) and 2 (suspected). These classifications are used across chemical legislation and are the basis for cosmetic...
MoCRA cosmetics - the "biggest" regulation change in the US On 29 December 2022, President Biden signed into law the Consolidated Appropriations Act, 2023. Modernization of Cosmetic Regulation. Act, “MoCRA”, is the first major update to the Food and Drug Administration's (FDA) cosmetics authorities since 1938 and introduces significant changes. MOCRA'S KEY PROVISIONS Sec. 605 Adverse Effect Adverse effects caused by the use of...
On 1 February 2022, the European Commission released Regulation (EU) 2022/135 amending Cosmetic Regulation as regards the use of Methyl-N-methylanthranilate in cosmetic products....
CBD cosmetics: Regulation about its use CBD is, without question, becoming increasingly popular in all kinds of products. The active ingredient comes from marijuana and has enormous therapeutic potential, and is now gaining traction in the cosmetics industry, too. Cannabis sativa is the botanical name for marijuana, and hemp. The difference between the two is the cannabinoid content:Marijuana: contains THC (psychotropic) and...